| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8550958 | Regulatory Toxicology and Pharmacology | 2018 | 7 Pages |
Abstract
The absence of toxicological effects following the injection of TMV SPs is promising for the further development of recombinant vaccine candidates with TMV SPs as an adjuvant.
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
N.A. Nikitin, V.A. Zenin, E.A. Trifonova, E.M. Ryabchevskaya, O.A. Kondakova, A.N. Fedorov, J.G. Atabekov, O.V. Karpova,